These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15900593)

  • 1. Frequent genomic abnormalities at TWIST in human pediatric osteosarcomas.
    Entz-Werlé N; Stoetzel C; Berard-Marec P; Kalifa C; Brugiere L; Pacquement H; Schmitt C; Tabone MD; Gentet JC; Quillet R; Oudet P; Lutz P; Babin-Boilletot A; Gaub MP; Perrin-Schmitt F
    Int J Cancer; 2005 Nov; 117(3):349-55. PubMed ID: 15900593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of MET/TWIST/APC combination or the potential role of ossification factors in pediatric high-grade osteosarcoma oncogenesis.
    Entz-Werle N; Lavaux T; Metzger N; Stoetzel C; Lasthaus C; Marec P; Kalifa C; Brugieres L; Pacquement H; Schmitt C; Tabone MD; Gentet JC; Lutz P; Babin A; Oudet P; Gaub MP; Perrin-Schmitt F
    Neoplasia; 2007 Aug; 9(8):678-88. PubMed ID: 17786187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIT gene in pediatric osteosarcomas: could it be a new therapeutic target?
    Entz-Werle N; Gaub MP; Lavaux T; Marcellin L; Metzger N; Marec-Berard P; Schmitt C; Brugiere L; Kalifa C; Tabone MD; Pacquement H; Gentet P; Lutz P; Oudet P; Babin A
    Int J Cancer; 2007 Jun; 120(11):2510-6. PubMed ID: 17294449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of allelic imbalance at the c-kit gene locus and c-kit overexpression by immunohistochemistry in pediatric osteosarcomas.
    Entz-Werlé N; Marcellin L; Gaub MP; Guerin E; Schneider A; Berard-Marec P; Kalifa C; Brugiere L; Pacquement H; Schmitt C; Tabone MD; Jeanne-Pasquier C; Terrier P; Dijoud F; Oudet P; Lutz P; Babin-Boilletot A
    J Clin Oncol; 2005 Apr; 23(10):2248-55. PubMed ID: 15800315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COPS3 amplification and clinical outcome in osteosarcoma.
    Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
    Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
    Wang Z; Cai H; Lin L; Tang M; Cai H
    Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas.
    Ozaki T; Schaefer KL; Wai D; Buerger H; Flege S; Lindner N; Kevric M; Diallo R; Bankfalvi A; Brinkschmidt C; Juergens H; Winkelmann W; Dockhorn-Dworniczak B; Bielack SS; Poremba C
    Int J Cancer; 2002 Dec; 102(4):355-65. PubMed ID: 12402305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation spectrum of the retinoblastoma gene in osteosarcomas.
    Wadayama B; Toguchida J; Shimizu T; Ishizaki K; Sasaki MS; Kotoura Y; Yamamuro T
    Cancer Res; 1994 Jun; 54(11):3042-8. PubMed ID: 8187094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization.
    Kresse SH; Ohnstad HO; Paulsen EB; Bjerkehagen B; Szuhai K; Serra M; Schaefer KL; Myklebost O; Meza-Zepeda LA
    Genes Chromosomes Cancer; 2009 Aug; 48(8):679-93. PubMed ID: 19441093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer.
    Lenos K; Grawenda AM; Lodder K; Kuijjer ML; Teunisse AF; Repapi E; Grochola LF; Bartel F; Hogendoorn PC; Wuerl P; Taubert H; Cleton-Jansen AM; Bond GL; Jochemsen AG
    Cancer Res; 2012 Aug; 72(16):4074-84. PubMed ID: 22700878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative genomic hybridization (CGH) for detecting a heretofore undescribed amplified chromosomal segment in high-grade medullary osteosarcoma].
    Brinkschmidt C; Blasius S; Bürger H; Simon R; Diallo R; Battmann A; Winkelmann W; Böcker W; Dockhorn-Dworniczak B
    Verh Dtsch Ges Pathol; 1998; 82():184-8. PubMed ID: 10095431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma.
    Onda M; Matsuda S; Higaki S; Iijima T; Fukushima J; Yokokura A; Kojima T; Horiuchi H; Kurokawa T; Yamamoto T
    Cancer; 1996 Jan; 77(1):71-8. PubMed ID: 8630943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twist is required for patterning the cranial nerves and maintaining the viability of mesodermal cells.
    Ota MS; Loebel DA; O'Rourke MP; Wong N; Tsoi B; Tam PP
    Dev Dyn; 2004 Jun; 230(2):216-28. PubMed ID: 15162501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profiles of osteosarcoma that can predict response to chemotherapy.
    Man TK; Chintagumpala M; Visvanathan J; Shen J; Perlaky L; Hicks J; Johnson M; Davino N; Murray J; Helman L; Meyer W; Triche T; Wong KK; Lau CC
    Cancer Res; 2005 Sep; 65(18):8142-50. PubMed ID: 16166288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays.
    Squire JA; Pei J; Marrano P; Beheshti B; Bayani J; Lim G; Moldovan L; Zielenska M
    Genes Chromosomes Cancer; 2003 Nov; 38(3):215-25. PubMed ID: 14506695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of DNA image cytophotometry for osteosarcoma.
    Neuburger M; Xia Y; Herget GW; Huang Y; Adler CP
    Anal Quant Cytol Histol; 1999 Dec; 21(6):461-7. PubMed ID: 10626013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor expression in high-grade osteosarcomas is associated with a good clinical outcome.
    Kersting C; Gebert C; Agelopoulos K; Schmidt H; van Diest PJ; Juergens H; Winkelmann W; Kevric M; Gosheger G; Brandt B; Bielack S; Buerger H
    Clin Cancer Res; 2007 May; 13(10):2998-3005. PubMed ID: 17505002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of promoter hypermethylation in multiple genes in osteosarcoma.
    Hou P; Ji M; Yang B; Chen Z; Qiu J; Shi X; Lu Z
    Cancer; 2006 Apr; 106(7):1602-9. PubMed ID: 16502411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma.
    Man TK; Lu XY; Jaeweon K; Perlaky L; Harris CP; Shah S; Ladanyi M; Gorlick R; Lau CC; Rao PH
    BMC Cancer; 2004 Aug; 4():45. PubMed ID: 15298715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of c-kit in human osteosarcoma and its relevance as a prognostic marker.
    Sulzbacher I; Birner P; Toma C; Wick N; Mazal PR
    J Clin Pathol; 2007 Jul; 60(7):804-7. PubMed ID: 17018686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.